Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
ID: 356077Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356077

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-022.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for a Cooperative Agreement to establish a Coordinating Center as part of a pilot program for Population Genomic Screening in Primary Care, under funding opportunity number RFA-HG-24-022. The initiative aims to implement evidence-based screening for 4-7 common genomic conditions, targeting an enrollment of 20,000 patients, with a minimum of 55% from health disparity populations, while enhancing community engagement and awareness of genetic conditions in diverse primary care settings. This funding opportunity emphasizes health equity and ethical considerations in genomic testing, with a project timeline spanning five years for protocol development, patient recruitment, data collection, and analysis. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for December 2, 2024.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HG-24-022-Full-Announcement.html
    RFA-HG-24-022.html
    The Department of Health and Human Services is inviting applications for a Coordinating Center within a pilot program for Population Genomic Screening in Primary Care, spearheaded by the National Institutes of Health (NIH). The initiative, under funding opportunity number RFA-HG-24-022, aims to implement evidence-based screening for common genomic conditions, primarily in diverse primary care settings. The network will consist of multiple Clinical Groups and a Sequencing Center, focusing on enhancing community engagement, following protocols for genomic screening, and increasing awareness of genetic conditions among underserved populations. The objectives include screening for 4-7 genomic conditions, achieving a target enrollment of 20,000 patients, and ensuring a minimum 55% enrollment from health disparity populations. The timeline encompasses protocol development, patient recruitment, data collection, and analysis over a 5-year period. The goal is to effectively integrate genomic screening into primary care and evaluate its impact on patient outcomes through collaboration with various stakeholders. This funding opportunity emphasizes the importance of health equity, including addressing ethical considerations around genomic testing and ensuring robust educational resources for primary care providers.
    Similar Opportunities
    Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for a pilot program focused on Population Genomic Screening in Primary Care, designated as RFA-HG-24-021. This initiative aims to implement and evaluate screening for common genomic conditions, particularly targeting diverse populations and addressing health disparities, with a goal of enrolling approximately 5,000 patients per Clinical Group. The program emphasizes the importance of community engagement, establishing screening protocols, and ensuring follow-up care, while collaborating with a Coordinating Center and a Sequencing Center to integrate genomic screening into primary care settings. The total funding available is approximately $3.85 million, distributed across 4-5 awards over five years, with applications due by December 2, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the "Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)" grant, aimed at establishing a Sequencing Center to support a new population screening network. This initiative focuses on providing genomic sequencing services for 20,000 study participants, particularly targeting actionable conditions identified by the CDC, such as hereditary breast and ovarian cancer and Lynch syndrome, while ensuring inclusive recruitment from health disparity populations. The program emphasizes collaboration with community stakeholders and primary care providers to enhance genomic testing and follow-up care, ultimately aiming to integrate genomic medicine into primary care and address health disparities. Interested applicants should note that the total budget for the first year is $600,000, with escalating costs for subsequent years, and the application deadline is December 2, 2024. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-023.html.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "SBIR Solutions to Enable Population Genomic Screening," aimed at soliciting Small Business Innovation Research (SBIR) grant applications from U.S. small businesses. The objective of this initiative is to develop innovative solutions that facilitate population genomic screening for common, actionable genomic conditions within primary care settings, addressing significant barriers such as logistical challenges, provider education, and follow-up procedures. This program is crucial for enhancing the readiness of primary care providers to manage genomic screening, particularly for conditions like hereditary breast cancer and Lynch syndrome. Grants of up to $400,000 are available for Phase I applications, with Phase II grants potentially reaching $2.15 million. Interested applicants should note that the submission window opens on November 1, 2024, with a deadline for applications set for December 2, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Small Business Technology Transfer (STTR) applications aimed at developing innovative solutions for population genomic screening, particularly for common genomic conditions in primary care settings. The initiative seeks to create technologies, services, and educational resources that address barriers to genomic screening, including management, awareness, and referral processes, while promoting community engagement and collaboration between primary care providers and specialized genomic centers. Eligible U.S.-based small businesses can apply for Phase I grants up to $400,000 and Phase II grants up to $2,150,000, with applications due by December 2, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-262.html.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Genomic Community Resources (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-124) aimed at supporting the development of genomic community resources through cooperative agreements. This initiative seeks to enhance genomic research by funding projects that demonstrate broad applicability and significant value, focusing on the creation of genomic informatics tools, biological material collections, and community engagement efforts. The funded projects will play a crucial role in advancing both basic and clinical genomics research, with awards potentially lasting up to five years. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by January 25, 2026, and can find further details and submission guidelines at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.